South Texas Accelerated Research Therapeutics (START) Midwest — Grand Rapids, Michigan

South Texas Accelerated Research Therapeutics (START) Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics (START) Midwest has participated in 16 clinical trials with 10 currently active.

Therapeutic areas: Advanced Solid Tumors, Metastatic Cancer, Solid Tumor.

Sponsors: Debiopharm International SA, Symphogen A/S, Chugai Pharmaceutical.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics (START) Midwest?

South Texas Accelerated Research Therapeutics (START) Midwest has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics (START) Midwest conducted?

South Texas Accelerated Research Therapeutics (START) Midwest has 16 clinical trials on record, with 10 currently active. Their work covers Advanced Solid Tumors, Metastatic Cancer, Solid Tumor.

Is South Texas Accelerated Research Therapeutics (START) Midwest accredited by Crixeo Health?

Yes — South Texas Accelerated Research Therapeutics (START) Midwest holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics (START) Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.